Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.

HIV and global health activists say the deployment of Gilead’s twice-a-year HIV prevention shot is the world’s best chance to ...

This week, a site in Colorado may have been used as the “largest lekking arena in the world” by dancing dinosaurs, a child ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

To really help, new HIV vax has to be made cheap  A pill to treat multidrug-resistant HIV, lenacapavir, has been approved by US drug regulator FDA as a preventive vaccine. This is a huge ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

The Food and Drug Administration approved a new vaccine to prevent HIV infection, lenacapavir, a long-acting injection, which ...

Researchers have provided more evidence that mpox virus can be passed from a pregnant mother to her child. There remain ...